Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pigment Cell Research

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1600-0749.2004.00128.XPMID 15016307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast growth factor‐2 but not Mel‐CAM and/or β3 integrin promotes progression of melanocytes to melanoma

  2003cited by this paper
• Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.

  2003cited by this paper
• The INK4a/ARF locus and melanoma

  2003cited by this paper
• Essential role of RelA Ser311 phosphorylation by ζPKC in NF‐κB transcriptional activation

  2003cited by this paper
• Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma

  2003cited by this paper
• Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation.

  2003influential reference
• Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway*

  2003cited by this paper
• NF-kappaB stimulates Akt phosphorylation and gene expression by distinct signaling mechanisms.

  2003cited by this paper
• The PI‐3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3

  2003cited by this paper
• NF-κB at the crossroads of life and death

  2002cited by this paper
• NF-?B regulation in the immune system

  2002cited by this paper
• Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit.

  2002cited by this paper
• NF-kappaB at the crossroads of life and death.

  2002cited by this paper
• RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100*

  2002cited by this paper
• Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.

  2002cited by this paper
• NF-kappaB regulation in the immune system.

  2002cited by this paper
• The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

  2002cited by this paper
• RelB-p50 NF-κB Complexes Are Selectively Induced by Cytomegalovirus Immediate-Early Protein 1: Differential Regulation of Bcl-xL Promoter Activity by NF-κB Family Members

  2002cited by this paper
• RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members.

  2002cited by this paper
• The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1

  2002cited by this paper
• Akt is a downstream target of NF-kappa B.

  2002influential reference
• Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit

  2002cited by this paper
• Akt Is a Downstream Target of NF-κB*

  2002cited by this paper
• Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.

  2002cited by this paper
• Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas

  2001cited by this paper
• RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B.

  2001influential reference
• Duration of nuclear NF-kappaB action regulated by reversible acetylation.

  2001cited by this paper
• Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.

  2001cited by this paper
• Loss of expression of protein kinase C β is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?

  2001cited by this paper
• Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38*

  2001cited by this paper
• The Role of NF-κB in TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis of Melanoma Cells1

  2001cited by this paper
• Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation

  2001cited by this paper
• Constitutive IκB Kinase Activity Correlates with Nuclear Factor-κB Activation in Human Melanoma Cells

  2001cited by this paper
• reply: Kinase regulation in inflammatory response

  2000cited by this paper
• Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.

  2000cited by this paper
• Signal-dependent and -independent Degradation of Free and NF-κB-bound IκBα*

  2000cited by this paper
• Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB

  2000cited by this paper
• Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II*

  2000cited by this paper
• Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice.

  2000cited by this paper
• Signalling pathways: Kinase regulation in inflammatory response

  2000cited by this paper
• Nuclear Factor-κB Activity Correlates with Growth, Angiogenesis, and Metastasis of Human Melanoma Cells in Nude Mice

  2000cited by this paper
• Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha.

  2000cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000cited by this paper
• Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views.

  1999cited by this paper
• Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription.

  1999cited by this paper
• Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit.

  1999cited by this paper
• Elevated Constitutive IκB Kinase Activity and IκB-α Phosphorylation in Hs294T Melanoma Cells Lead to Increased Basal MGSA/GRO-α Transcription

  1999cited by this paper
• Mechanisms by which IkappaB proteins control NF-kappaB activity.

  1999cited by this paper
• Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress.

  1999cited by this paper
• Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-κB p65/RelA Subunit

  1999cited by this paper
• Heavily pigmented melanocytic neoplasms: comparison of two melanin-bleaching techniques and subsequent immunohistochemical staining.

  1999cited by this paper
• Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.

  1998cited by this paper
• Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study.

  1998influential reference
• Alternative Splicing Variants of IκBβ Establish Differential NF-κB Signal Responsiveness in Human Cells

  1998cited by this paper
• Malignant melanoma: modern black plague and genetic black box.

  1998influential reference
• Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300.

  1998cited by this paper
• A novel DNA-binding motif shares structural homology to DNA replication and repair nucleases and polymerases

  1998cited by this paper
• Expression of apoptosis regulators in cutaneous malignant melanoma.

  1998cited by this paper
• A novel DNA recognition mode by the NF-kappa B p65 homodimer.

  1998cited by this paper
• IκB kinase: Beginning, not the end

  1997cited by this paper
• Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells

  1997cited by this paper
• I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity

  1997cited by this paper
• IkappaB kinase: beginning, not the end.

  1997cited by this paper
• Activate NF-kappa B or die?

  1997cited by this paper
• Apoptosis: Activate NF-κB or die?

  1997cited by this paper
• Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.

  1997cited by this paper
• Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases

  1997cited by this paper
• Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit*

  1997cited by this paper
• Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells.

  1997cited by this paper
• I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

  1997cited by this paper
• Distinct functional properties of IkappaB alpha and IkappaB beta

  1997cited by this paper
• TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB

  1996cited by this paper
• Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta

  1996cited by this paper
• TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

  1996cited by this paper
• Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha

  1996cited by this paper
• NF-κB: Ten Years After

  1996cited by this paper
• NF-kappa B: ten years after.

  1996cited by this paper
• Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product

  1996cited by this paper
• Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability

  1996cited by this paper
• Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

  1995cited by this paper
• Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

  1995cited by this paper
• Constitutive phosphorylation of I kappa B alpha by casein kinase II.

  1995cited by this paper
• Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

  1995cited by this paper
• I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B.

  1995cited by this paper
• Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas.

  1990cited by this paper
• Two kinds of "clear" cells in the human epidermis; with a report of a modified DOPA reaction for electron microscopy.

  1961cited by this paper

• Updates in clinical trial-explored chemopreventive agents for cutaneous melanoma: mechanisms affecting melanocytes

  2025cites this paper
• Oxidative State in Cutaneous Melanoma Progression: A Question of Balance

  2024cites this paper
• Deciphering the Intricate Dynamics of Inflammasome Regulation in Visceral and Post-Kala-Azar Dermal Leishmaniasis: A Meta-Analysis of Consistencies.

  2024cites this paper
• Targeting Melanoma with a phytochemical pool: Tailing Makisterone C

  2023cites this paper
• Bioelectric Dysregulation in Cancer Initiation, Promotion, and Progression

  2022cites this paper
• Association of the 609 C/T NAD(P)H: quinone oxidoreductase (NQO1) polymorphism with development of cutaneous malignant melanoma

  2022cites this paper
• Cutaneous melanoma: An update on pathogenesis, prevention, and treatment

  2022cites this paper
• Dipotassium Glycyrrhizinate on Melanoma Cell Line: Inhibition of Cerebral Metastases Formation by Targeting NF-kB Genes-Mediating MicroRNA-4443 and MicroRNA-3620—Dipotassium Glycyrrhizinate Effect on Melanoma

  2022cites this paper
• The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways

  2020cites this paper
• c‐Rel is a cell cycle modulator in human melanoma cells

  2019cites this paper
• Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective

  2019cites this paper
• Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes

  2019cites this paper
• Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome

  2019cites this paper
• Oxidative stress and antioxidants in the pathophysiology of malignant melanoma

  2018cites this paper
• Proteasome Inhibitor Carbobenzoxy-L-Leucyl-L-Leucyl-L-Leucinal (MG132) Enhances Therapeutic Effect of Paclitaxel on Breast Cancer by Inhibiting Nuclear Factor (NF)-κB Signaling

  2018cites this paper
• Cancer as a disorder of patterning information: computational and biophysical perspectives on the cancer problem

  2017cites this paper
• Neokestose suppresses the growth of human melanoma A2058 cells via inhibition of the nuclear factor‑κB signaling pathway.

  2017cites this paper
• Melanoma Chemoprevention: Current Status and Future Prospects

  2017cites this paper
• Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care

  2017cites this paper
• Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC

  2017cites this paper
• The double life of RIPK1

  2016cites this paper
• DR5 mAb-conjugated, DTIC-loaded immuno-nanoparticles effectively and specifically kill malignant melanoma cells in vivo

  2016cites this paper
• Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma.

  2016cites this paper
• Appendix to “Mining Massive Amounts of Genomic Data: A Semiparametric Topic Modeling Approach”

  2016cites this paper
• Ursolic Acid and Chronic Disease: An Overview of UA's Effects On Prevention and Treatment of Obesity and Cancer.

  2016cites this paper
• The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model.

  2016cites this paper
• Role of RAGE in melanoma development, growth, and progression

  2016cites this paper
• microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB

  2016cites this paper
• The effect of antioxidants on UV-irradiated melanocytes and melanoma cells

  2015cites this paper
• RIP1 Kinase Is an Oncogenic Driver in Melanoma.

  2015cites this paper
• Prognostic role of BRAF in human cutaneous melanoma : gene versus protein expression

  2015cites this paper
• MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma

  2015cites this paper
• c-FLIPp43 induces activation of the nuclear factor‑κB signaling pathway in a dose-dependent manner in the A375 melanoma cell line.

  2014cites this paper
• Histone Deacetylase Inhibitor Sensitizes Apoptosis-Resistant Melanomas to Cytotoxic Human T Lymphocytes through Regulation of TRAIL/DR5 Pathway

  2014cites this paper
• A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology

  2014cites this paper
• Molecular Pathology of Melanocytic Skin Cancer

  2014cites this paper
• BRAF inhibitor therapy for melanoma, thyroid and colorectal cancers: development of resistance and future prospects.

  2014cites this paper
• The gp82 surface molecule of Trypanosoma cruzi metacyclic forms.

  2014cites this paper
• A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for VariousEndpoints ofMelanoma Pathobiology

  2014cites this paper
• A Randomized, Double-Blind, Placebo-Controlled Phase II ClinicalTrialofLovastatinforVariousEndpointsofMelanoma Pathobiology

  2014cites this paper
• The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα.

  2014cites this paper
• Regulation of MSK1‐Mediated NF‐κB Activation Upon UVB Irradiation

  2014cites this paper
• Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis.

  2014cites this paper
• Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer.

  2014cites this paper
• Pathobiology Clinical Trial of Lovastatin for Various Endpoints of Melanoma A Randomized , Double-Blind , Placebo-Controlled Phase II

  2014cites this paper
• Combined inhibition of NF-κB and Bcl-2 triggers synergistic reduction of viability and induces apoptosis in melanoma cells.

  2014cites this paper
• Aspirin and Other NSAIDs as Chemoprevention Agents in Melanoma

  2014cites this paper
• Targeted Therapies in Melanoma: Successes and Pitfalls

  2013cites this paper
• Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model

  2013cites this paper
• UVB-Stimulated TNFα Release from Human Melanocyte and Melanoma Cells Is Mediated by p38 MAPK

  2013cites this paper
• Melanoma: Treatments and Resistance

  2013cites this paper
• Systematic approaches to overcoming limitations of MAPK pathway inhibition in melanoma

  2013cites this paper
• Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression.

  2012cites this paper
• NF-κB as potential target in the treatment of melanoma

  2012cites this paper
• Role of Sox4 transcription factor in human cutaneous melanoma

  2012cites this paper
• Molecular Pathogenesis of Melanoma: Established and Novel Pathways

  2012cites this paper
• Prevention of Obesity, Diabetes, and Cancer with Lifestyle Intervention Strategies

  2012cites this paper
• Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.

  2011cites this paper
• Suicidal gene therapy in an NF-κB-controlled tumor environment as monitored by a secreted blood reporter

  2011cites this paper
• Novel biosensors for preclinical brain tumor analysis

  2011cites this paper
• Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model.

  2011cites this paper
• Spitz Nevi Arising in Speckled Lentiginous Nevus: Clinical, Histologic, and Molecular Evaluation of Two Cases

  2011cites this paper
• Bioluminescence imaging in glioblastoma: monitoring of biological processes and novel therapeutics

  2010cites this paper
• IKKγ protein is a target of BAG3 regulatory activity in human tumor growth

  2010cites this paper
• Abstract. Nuclear factor (NF)-κB is one of the most impor- tant transcription factors that plays a crucial role in the regulation of a wide spectrum of genes involved in modulating the cell cycle, apoptosis, cell growth, angiogenesis, inflam-

  2010cites this paper
• Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma.

  2010cites this paper
• Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin‐6 expression

  2009cites this paper
• NEMO-binding domain peptide inhibits proliferation of human melanoma cells.

  2009cites this paper
• Real-Time Monitoring of Nuclear Factor κB Activity in Cultured Cells and in Animal Models

  2009cites this paper
• Vanillin Inhibits Matrix Metalloproteinase-9 Expression through Down-Regulation of Nuclear Factor-κB Signaling Pathway in Human Hepatocellular Carcinoma Cells

  2009cites this paper
• Apurinic/Apyrimidinic Endonuclease/Redox Effector Factor-1(APE/Ref-1): A Unique Target for the Prevention and Treatment of Human Melanoma

  2009cites this paper
• Melanosomal Damage in Normal Human Melanocytes Induced by UVB and Metal Uptake—A Basis for the Pro‐oxidant State of Melanoma †

  2008cites this paper
• Evaluation of survivin and NF‐κB in psoriasis, an immunohistochemical study

  2008cites this paper
• Targeted Therapy in Melanoma

  2008cites this paper
• Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.

  2008cites this paper
• A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells

  2008cites this paper
• Rac1 activity regulates proliferation of aggressive metastatic melanoma.

  2007cites this paper
• mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.

  2007cites this paper
• Broad spectrum identification of SUMO substrates in melanoma cells

  2007cites this paper
• Reciprocal Modifications of CLIC4 in Tumor Epithelium and Stroma Mark Malignant Progression of Multiple Human Cancers

  2007cites this paper
• New perspectives on melanoma pathogenesis and chemoprevention.

  2007cites this paper
• Pocket protein function in melanocyte homeostasis and neoplasia.

  2006cites this paper
• Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration.

  2006cites this paper
• NF-kappaB activation in melanoma.

  2006cites this paper
• Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN.

  2006cites this paper
• NF‐κB activation in melanoma

  2006cites this paper
• Activation of the NF‐κB system in peripheral blood leukocytes from patients with chronic heart failure

  2005cites this paper
• Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure.

  2005cites this paper
• Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor

  2005cites this paper
• Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells.

  2005influential citation
• Role of nuclear factor-κ B in melanoma

  2005influential citation
• Role of nuclear factor-kappa B in melanoma.

  2005cites this paper
• Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations.

  2005cites this paper
• Of Trail/dr5 Pathway Human T Lymphocytes through Regulation Apoptosis-resistant Melanomas to Cytotoxic Histone Deacetylase Inhibitor Sensitizes

  year unknowncites this paper
• UC Irvine UC Irvine Previously Published Works Title New perspectives on melanoma pathogenesis and chemoprevention

  year unknowncites this paper
• International Journal of Nanomedicine Dovepress Dovepress Anti-dr5 Monoclonal Antibody-mediated Dtic-loaded Nanoparticles Combining Chemotherapy and Immunotherapy for Malignant Melanoma: Target Formulation Development and in Vitro Anticancer Activity

  year unknowncites this paper